Tom O'Connor
Associate
Tom is an associate in our corporate finance team, specialising in capital markets transactions - including public company IPOs, secondary issues, mergers and acquisitions and general corporate advisory matters.
Associate
Tom is an associate in our corporate finance team, specialising in capital markets transactions - including public company IPOs, secondary issues, mergers and acquisitions and general corporate advisory matters.
Languages - English
Jurisdiction(s) - Queensland, Australia
Tom advises clients on a wide range of corporate finance transactions, including public company IPOs and secondary issues — acting for both issuers and banks — as well as private and public company acquisitions and general company law matters. He has experience working with UK, Australian, and international clients across sectors such as mining and exploration, healthcare, life sciences, and technology.
Cavendish
“Advising Cavendish in its role as nominated adviser, bookrunner and broker to MHA plc on MHA plc's initial public offering on the AIM market of the London Stock Exchange”Dr. Falk Pharma GmbH
“Advising Dr Falk on the successful acquisition of Kynos Therapeutics Ltd in a complex, cross-border transaction”Novacyt S.A.
“Advising Novacyt on the successful acquisition of Yourgene Health plc by recommended takeover in a Takeover Code governed transaction effected by a court-sanctioned scheme of arrangement”Liberum Capital
“Advising Liberum Capital on its merger with Panmure Gordon to create the UK's largest independent investment bank” Stephenson Harwood advises Liberum on Panmure Gordon merger
